Drug Class
complement inhibitor
Type
brand
Active Ingredient
pegcetacoplan
📋Overview
Empaveli is a medication that targets the complement system, a part of the immune system involved in inflammation and cell destruction. It is primarily associated with the management of rare blood disorders, particularly those involving abnormal breakdown of red blood cells. Empaveli is most notably linked to paroxysmal nocturnal hemoglobinuria (PNH), a condition characterized by hemolysis and related complications. Its use reflects advances in therapies for complement-mediated diseases.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Empaveli
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.